Market Overview The recombinant proteins market is central to modern vaccine development through subunit, virus-like particle, and recombinant protein antigen platforms that offer superior safety profiles compared to live-attenuated or inactivated whole-pathogen vaccines. Recombinant hepatitis B surface antigen, human papillomavirus virus-like particles, and acellular pertussis components...